GlassScriptPhysician profile
Nainesh C Patel
NPI 1851361810
$133,913.11
in general payments reported to CMS, 2019-2025
24 companies · $8,642 in 2025
The $8,642 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $37K · 2021: $17K · 2022: $14K · 2023: $13K · 2024: $12K · 2025: $8,642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,404 · Travel and Lodging: $8,712 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,844 · Honoraria: $4,000 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,300 · Consulting Fee: $1,100 · Education: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,404.48 |
| Travel and Lodging | $8,711.55 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,843.75 |
| Honoraria | $4,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,300.00 |
| Consulting Fee | $1,100.00 |
| Education | $127.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $33,969.20 | 2019-2021 | |
| Penumbra, INC. | $25,980.90 | 2019-2025 | Indigo System |
| Medtronic, INC. | $19,542.12 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Medtronic Vascular, INC. | $17,371.65 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7,760.74 | 2019-2024 | Lifevest |
| Lilly USA, LLC | $7,425.00 | 2019-2021 | |
| Abbott Laboratories | $6,674.53 | 2019-2025 | Mitraclip, Tendyne, Triclip |
| Shockwave Medical, INC | $5,072.93 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $3,552.06 | 2019-2025 | Impella |
| Boston Scientific Corporation | $3,288.50 | 2019-2025 | Avvigo Guidance System, General - Atherectomy, General - Balloon Catheters |
| Edwards Lifesciences Corporation | $2,490.21 | 2019-2025 | Evoque, Sapien 3 Ultra Resilia, Pascal |
| E.R. Squibb & Sons, L.L.C. | $195.15 | 2021-2023 | |
| Imperative Care, INC | $87.34 | 2023 | Zoom 88-T Large Distal Platform |
| Surmodics, INC. | $86.23 | 2022 | |
| Terumo Medical Corporation | $80.70 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $78.93 | 2019 | |
| Chiesi USA, INC. | $72.28 | 2019 | |
| Johnson & Johnson Health Care Systems INC. | $50.88 | 2021 | |
| Endotronix, INC. | $49.01 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
| Amarin Pharma, INC. | $30.11 | 2020-2021 | |
| Pfizer INC. | $27.27 | 2025 | |
| Atricure, INC. | $24.09 | 2021 | |
| Cardiovascular Systems INC. | $3.28 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nainesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.